Table 4.
Small organic molecules with the known biofilm inhibition or eradication mechanism.
Small Organic Molecules | Biological Role | Effective Against | Type of Compound | Reference | |
---|---|---|---|---|---|
1 | 5-phenyl-2-aminoimidazole | Reduction in transription of CsgD, csgB and adrA | S. typhimurium | Imidazole derivative | [79] |
2 | ABC-1 | Reduction in SpA and PIA production and decrease eDNA release | S. aureus, Gram-positive and Gram-negative pathogens | Imidazole derivative | [1,80] |
3 | 5,6-dimethoxy-2-aminobenzimidazole | Reduction in QS receptors (LasR and RhlR) | P. aeruginosa | Imidazole derivative | [81] |
4 | Pyrazolo-pyrimido [4,5-d] pyrimidines | ROS accumulation, loss of membrane integrity | M. luteus, S. aureus, B. subtilis, E. coli, K. planticola | pyrazole compound | [82,83,84] |
5 | Indole-3-carboxaldehyde and 3-indolylacetonitrile | Reduction of curli production | E. coli, P. aeruginosa | indole and carbazole derivative | [85,86] |
6 | Phenylhydrazine analogues | SrtA inhibition | S. aureus | 2-Phenylhydrazineylidene derivatives | [87] |
7 | Diethyl 1-(2-chlorophenyl)-4-((3-chlorophenyl)amino)-5-oxo-2,5-dihydr-1H-pyrrole-2,3-dicarboxylate | MDH and eDNA inhibition | P. aeruginosa | Pyrrole derivatives | [90] |
8 | (Z)-5-bromomethylene-2(5H)-furanone | AI-2-mediated QS inhibition | S. anginosus, S.intermedius and S. mutans | Furanone and oxazolidinone derivatives | [91] |
9 | Bicyclic brominated furanones | AI-2-mediated QS inhibition | F. nucleatum, P. gingivalis and T. forsythia | Furanone and oxazolidinone derivatives | [91] |
10 | Halogenated phenazine | Bind with copper (II ) and iron (II) | MRSA, MRSE, and VRE | Phenazine and quinolone derivative | [92] |
11 | Quinolone compound Ia | PqsR inhibition | P. aeruginosa | Quinolone derivative | [93] |
12 | 3,4-dimethoxycinnamide derivative | LecB inhibition | P. aeruginosa | Cinnamide derivative of d-mannose | [94] |